Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Sarcoidosis extent relates to molecular variability.

Monast CS, Li K, Judson MA, Baughman RP, Wadman E, Watt R, Silkoff PE, Barnathan ES, Brodmerkel C.

Clin Exp Immunol. 2017 Jun;188(3):444-454. doi: 10.1111/cei.12942. Epub 2017 Mar 27.

2.

Identifying Determinants of EGFR-Targeted Therapeutic Biochemical Efficacy Using Computational Modeling.

Monast CS, Lazzara MJ.

CPT Pharmacometrics Syst Pharmacol. 2014 Oct 15;3:e141. doi: 10.1038/psp.2014.39.

3.

Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.

Ercan D, Xu C, Yanagita M, Monast CS, Pratilas CA, Montero J, Butaney M, Shimamura T, Sholl L, Ivanova EV, Tadi M, Rogers A, Repellin C, Capelletti M, Maertens O, Goetz EM, Letai A, Garraway LA, Lazzara MJ, Rosen N, Gray NS, Wong KK, Jänne PA.

Cancer Discov. 2012 Oct;2(10):934-47. doi: 10.1158/2159-8290.CD-12-0103. Epub 2012 Sep 7.

4.

Computational analysis of the regulation of EGFR by protein tyrosine phosphatases.

Monast CS, Furcht CM, Lazzara MJ.

Biophys J. 2012 May 2;102(9):2012-21. doi: 10.1016/j.bpj.2012.03.037.

Supplemental Content

Loading ...
Support Center